SENIF FARMA SL
Company details
- Active NIF/CIF: B91228312
-
-
-
-
Address: Calle Calahoyas, 33, 41927 Mairena del Aljarafe, Sevilla, España See in map
-
-
Featured products:
More information on SENIF FARMA SL
-
20/03/2009 | BORME act no.: 97019 | Register: SEVILLADepósito de cuentas anuales (Marzo de 2009)
-
20/03/2009 | BORME act no.: 97097 | Register: SEVILLADepósito de cuentas anuales (Marzo de 2009)
-
20/03/2009 | BORME act no.: 97233 | Register: SEVILLADepósito de cuentas anuales (Marzo de 2009)
-
11/06/2007 | BORME act no.: 192161 | Register: SEVILLADepósito de cuentas anuales (Mayo de 2007)
-
26/12/2002 | BORME act no.: 520451 | Register: SEVILLAConstitución
-
26/12/2002 | BORME act no.: 520451 | Register: SEVILLADeclaración de unipersonalidad
Other information
The CIF assigned to SENIF FARMA SL is B91228312, and its business status is active. The company is engaged in an economic activity classified within the CNAE 4611 - Intermediaries involved in the trade of agricultural raw materials, live animals, textile raw materials and semi-finished goods. In addition, its SIC identification - also defines it.
SENIF FARMA SL employs a team of Between 10 and 49 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Sevilla, and has - executive positions. Its most recent announcement in the Borme was published on 20/03/2009, while its last deposit of ordinary annual accounts is for the - fiscal year.
To access the contact information of SENIF FARMA SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about SENIF FARMA SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about SENIF FARMA SL is extracted from official sources and is updated daily.
Do you want to know more about SENIF FARMA SL??
Find out more about this company by consulting these reports: